AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6

Fiasp FlexTouch (3ml Each)

Prescription Icon
Prescription Required

Marketer

Novo Nordisk India Pvt Ltd

Salt Composition

Insulin Aspart (100IU/ml)

Overview Fiasp FlexTouch (3ml Each)

For individuals with type 1 or type 2 diabetes, Fiasp FlexTouch (3ml vials) helps manage blood glucose. This rapid-acting insulin lowers post-meal sugar, mitigating the risk of diabetes-related complications. Fiasp FlexTouch is typically administered alongside a longer-acting insulin or other diabetic medications, injected subcutaneously as instructed by your healthcare provider – ideally, at meal onset or within 20 minutes. Regular blood glucose monitoring, meticulous record-keeping, and doctor consultation are crucial for optimal dosage determination. Avoid use if hypoglycemic. Prior kidney, liver, or heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require physician consultation for potential dosage adjustments. Discontinue use only under medical supervision. This medication complements a comprehensive diabetes management plan, encompassing healthy eating, exercise, and weight management as recommended by your doctor. Common adverse reactions include hypoglycemia, headaches, nasopharyngitis, and upper respiratory infections; preventative measures include precise dosing, consistent meals, and diligent blood glucose monitoring. Excessive alcohol intake can exacerbate hypoglycemia. Additional side effects may involve injection site reactions (redness, swelling, lipodystrophy) and weight gain.

Primary Ingredients of Fiasp FlexTouch (3ml Each)

No text provided to rephrase.

Uses of Fiasp FlexTouch (3ml Each)

Managing Diabetes

Major Benefits of Fiasp FlexTouch (3ml Each):

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of Fiasp FlexTouch (3ml Each):

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Upper respiratory tract infection

How to use Fiasp FlexTouch (3ml Each):

Your healthcare provider will instruct you on the proper administration of this medication.

How Fiasp FlexTouch (3ml Each) works:

NovoRapid FlexPen (3ml) is a rapid-acting insulin analog. Its onset of action is observed within 10–20 minutes post-injection. It mimics the function of endogenous insulin by promoting glucose absorption into muscle and adipose tissue, and suppressing hepatic glucose production.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Fiasp FlexTouch (3ml Each) with alcohol is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Fiasp FlexTouch (3ml per pen) is typically deemed safe during gestation. Preclinical trials in animals have revealed minimal or absent negative impacts on fetal development; data from human trials, however, remain scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Using Fiasp FlexTouch (3ml vials) while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no known harm to infants.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Fiasp FlexTouch (3ml Each) cautiously, potentially requiring dosage modification. Physician consultation is advised. Routine blood glucose monitoring is necessary to guide appropriate dosage adjustments.

LiverLiverCAUTION

Patients with hepatic impairment should use Fiasp FlexTouch (3ml vials) cautiously; dosage modification may be necessary. Physician consultation is recommended. Close, consistent blood glucose monitoring is advised.

What if you forget to take Fiasp FlexTouch (3ml Each) :

Failure to administer a scheduled dose of Fiasp FlexTouch (3ml vials) may result in elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust subsequent dosing as needed.

Facts to Know About Fiasp FlexTouch (3ml Each)

LabelValue
Chemical Classification Modified insulin
Developing Habits No.
Treatment Category Diabetes Management
Action Class Fast-acting insulin analogs

FAQs on Fiasp FlexTouch (3ml Each)

Fiasp FlexTouch (3ml Each), an insulin analog, is an anti-diabetic medication for adults and children aged 2 and older. It helps manage blood sugar and improve glycemic control.
Fiasp FlexTouch (3ml Each) is a fast-acting insulin aspart analog, produced via recombinant DNA technology using *Saccharomyces cerevisiae*. This sterile, clear, colorless solution contains insulin aspart, glycerin, phenol, metacresol, zinc, sodium chloride, and other components.
Fiasp FlexTouch (3ml Each) dosage is individualized. Always use this medication as directed by your doctor. It's typically combined with intermediate- or long-acting insulin and injected subcutaneously 5-10 minutes before a meal, or immediately afterward. Ensure you eat within 10 minutes of injection to prevent hypoglycemia.
Fiasp FlexTouch (3ml Each) can cause weight gain, whether used independently or with other insulin treatments. This is a frequent side effect, primarily due to reduced glucose excretion in urine and the insulin's anabolic effects, promoting fat and protein synthesis. Consult your doctor to determine the specific cause and appropriate management.
Type 1 diabetes requires lifelong Fiasp FlexTouch (3ml Each) because the body doesn't produce enough insulin. Conversely, for Type 2 diabetes, Fiasp FlexTouch (3ml Each) may be discontinued if blood sugar is effectively managed through diet, exercise, and oral medications.
Fiasp FlexTouch (3ml Each) can lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as candy, glucose biscuits, or juice.
Fiasp FlexTouch (3ml Each) is a rapid-acting insulin for managing blood sugar in individuals with diabetes. Its faster action compared to regular insulin helps control post-meal glucose spikes, allowing for subcutaneous injection 5-10 minutes before meals. It may also be administered post-meal if a dose is missed.
Fiasp FlexTouch (3ml Each) is safe for pregnant individuals when prescribed and managed by a doctor. Expect adjustments to your dosage and increased blood glucose monitoring. Consult your doctor if you are pregnant, planning a pregnancy, or are currently using Fiasp FlexTouch (3ml Each).
Fiasp FlexTouch (3ml Each...
913
MRP 1,006
9% off